Home > Insider Trading > Filing (0001209191-20-030349)

Filing Details

Accession Number:: 0001209191-20-030349
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-05-19 12:58:02
Reporting Period:: 2020-05-13

Accepted Time:: 2020-05-19 12:58:02
Original Submission Date:: 2020-05-15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610853	Helius Medical Technologies Inc.	HSDT	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1201810	Dane Andreeff	C/O Helius Medical Technologies Inc. 642 Newtown Yardley Road Newtown PA 18940		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2020-05-13	80,954	$0.57	701,389	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2020-05-13	17,038	$0.57	149,042	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2020-05-13	47,430	$0.57	396,529	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2020-05-13	4,578	$0.57	17,004	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2020-05-14	26,985	$0.56	728,374	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2020-05-14	5,679	$0.56	154,721	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2020-05-14	15,810	$0.56	412,339	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2020-05-14	1,526	$0.56	18,530	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

This Form 4/A is being filed to amend the disclosure in Table I, Column 3 in the Form 4 previously filed on May 15, 2020, by the reporting person in order to disclose the code of the transaction as an open market purchase.
The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities held by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.